Ro Highlights AI Triage Tool Aimed at Improving Patient Response Times

A LinkedIn post from Ro highlights the company’s use of an in-house, LLM-based side effect triage tool to support patient care. According to the post, the AI system is designed to identify and route patient-reported side effects to the appropriate care team.

The post cites performance metrics suggesting operational gains, including a reduction in median response times from under 2 hours to 33 minutes and responses to urgent messages in under 26 minutes. It also points to a reported 70%+ improvement in care team response time across 24/7 coverage.

For investors, these figures may indicate early efficiency benefits from Ro’s AI investments, particularly in patient support workflows that can be expensive to scale with headcount alone. If sustainable, faster triage and routing could improve patient satisfaction, bolster retention, and support margin expansion in Ro’s virtual care model.

The use of an internally built LLM-based tool also suggests Ro is developing proprietary infrastructure rather than relying solely on off-the-shelf solutions. This approach could strengthen the company’s competitive positioning in digital health, though it may also entail ongoing R&D and compliance costs, especially around safety, accuracy, and regulatory expectations for AI in clinical workflows.